Sol-Gel Technologies Ltd.
COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS

Last updated:

Abstract:

Provided herein is a topical composition comprising roflumilast, roflumilast N-oxide or salts thereof as an active agent. The active agent in the composition of this invention is in encapsulated or non-encapsulated form, according to need. The above composition is useful for the treatment, prevention or alleviation of a skin disorder selected from Hidradenitis suppurativa and Prurigo nodularis.

Status:
Application
Type:

Utility

Filling date:

3 Feb 2021

Issue date:

5 Aug 2021